Stevens A, Little J, Kerr S, Kilbane P, Doherty C
Department of Public Health, Parkside Health Authority, London.
BMJ. 1990 Feb 17;300(6722):447-9. doi: 10.1136/bmj.300.6722.447.
One hundred and twenty eight British and Irish nephrologists were questioned about their policy for HIV testing of patients with end stage renal failure being considered for renal replacement therapy. A total of 101 (79%) replied. In the case of candidates for dialysis roughly one third of respondents tested only people they considered at risk of infection with HIV and nearly one fifth considered testing unnecessary. In the case of candidates for transplantation routine HIV testing was carried out by 68 of 100 nephrologists; 22 tested only patients "at risk" and 10 did not test. A positive HIV test result was considered by most but not all respondents (63/86) to exclude patients from transplantation. Twenty four of 88 nephrologists considered that HIV positivity should exclude patients from haemodialysis, but only seven of 87 would exclude such patients from peritoneal dialysis. Similar attitudes pertained for patients with end stage renal failure who refused HIV testing. Testing with the patient's knowledge and consent was the policy of two thirds of nephrologists, but a patient's signature was obtained by only 24 of 88. There should be a consensus on practice for HIV testing of patients with end stage renal failure.
128名英国和爱尔兰的肾病学家被问及他们对考虑接受肾脏替代治疗的终末期肾衰竭患者进行HIV检测的政策。共有101人(79%)进行了回复。对于透析候选人,约三分之一的受访者仅对他们认为有感染HIV风险的人进行检测,近五分之一的人认为检测没有必要。对于移植候选人,100名肾病学家中有68人进行常规HIV检测;22人仅对“有风险”的患者进行检测,10人不进行检测。大多数但并非所有受访者(63/86)认为HIV检测呈阳性应排除患者进行移植。88名肾病学家中有24人认为HIV阳性应排除患者进行血液透析,但87人中只有7人会排除此类患者进行腹膜透析。对于拒绝HIV检测的终末期肾衰竭患者也有类似态度。三分之二的肾病学家的政策是在患者知晓并同意的情况下进行检测,但88人中只有24人获得了患者的签名。对于终末期肾衰竭患者的HIV检测实践应该达成共识。